SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000019
Filing Date
2017-04-20
Accepted
2017-04-20 10:38:23
Documents
17
Period of Report
2017-04-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kmarch2017mor_04202017.htm 8-K 35570
2 EXHIBIT 99.1 di402marchmor.htm EX-99.1 4396
3 di402marchmor001.jpg GRAPHIC 93868
4 di402marchmor002.jpg GRAPHIC 25888
5 di402marchmor003.jpg GRAPHIC 14454
6 di402marchmor004.jpg GRAPHIC 119586
7 di402marchmor005.jpg GRAPHIC 217410
8 di402marchmor006.jpg GRAPHIC 144904
9 di402marchmor007.jpg GRAPHIC 76163
10 di402marchmor008.jpg GRAPHIC 118798
11 di402marchmor009.jpg GRAPHIC 131523
12 di402marchmor010.jpg GRAPHIC 153667
13 di402marchmor011.jpg GRAPHIC 73491
14 di402marchmor012.jpg GRAPHIC 82393
15 di402marchmor013.jpg GRAPHIC 153923
16 di402marchmor014.jpg GRAPHIC 120212
17 di402marchmor015.jpg GRAPHIC 125438
  Complete submission text file 0001338095-17-000019.txt   2285134
Mailing Address P.O. BOX 400 JAMISON PA 18929
Business Address P.O. BOX 400 JAMISON PA 18929 6095538887
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17771800
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences